Please select the option that best describes you:
Topics:
Breast Cancer • Medical Oncology • Breast Cancer, Non-metastatic • HER+ • Premenopausal • pertuzumab
Would you add pertuzumab to adjuvant therapy for a premenopausal female with HR+, HER2+ IDC with N1mic disease?
ER 90%, HER2 3+
18mm tumor
1 out of 3 SLN with 0.25mm micro metastasis